Moderna Inc. (0QF)
Munich
Closed
Oct 23, 2026
Day's Range
173.4052 wk Range
19.59Overview - 0QF - Moderna Inc.
Key Statistics
Valuation
Enterprise Value
64.80B
P/E (Trailing)
25.19
PEG Ratio
-3.35
Price / Sales (TTM)
34.31
Price / Book
12.65
EV / EBITDA
-33.07
Profitability
Gross Margin
34.96%
Profit Margin
-141.42%
Operating Margin
-557.93%
Return on Assets
-13.25%
Return on Equity
-38.99%
Ownership
Shares Outstanding
399.00M
Float
372.06M
Held by Insiders
7.33%
Held by Institutions
80.41%
Price stats
Beta
1.09
50-Day Avg
120.57
200-Day Avg
63.51
Dividends
Payout Ratio
0.00%
Market Cap - 0QF - Moderna Inc.
Peers - 0QF - Moderna Inc.
Peer Comparison
Compared with companies in Biotechnology listed on Munich.
- 0QFMunichModerna Inc.78.99BMarket Cap+88.34%52-week change25.19P/E (Trailing)-141.42%Profit Margin
- 1AEAMunichargenx SE American Depositary Receipt45.08BMarket Cap+4.14%52-week change36.67P/E (Trailing)32.26%Profit Margin
- 5VAMunichVaxcyte Inc.9.68BMarket Cap+39.35%52-week change-11.01P/E (Trailing)0.00%Profit Margin
- 30JMunichIDEAYA Biosciences Inc.3.20BMarket Cap+29.48%52-week change-26.37P/E (Trailing)-74.75%Profit Margin
- 0MEMunichTwist Bioscience Corporation3.10BMarket Cap+80.52%52-week change-107.77P/E (Trailing)50.72%Profit Margin
- 6461MunichIntech Biopharm Corporation2.66BMarket Cap-18.06%52-week change—P/E (Trailing)-103.17%Profit Margin
- 4DNMunichDenali Therapeutics Inc.2.55BMarket Cap+8.15%52-week change-5.39P/E (Trailing)0.00%Profit Margin
Profile Summary - 0QF - Moderna Inc.
About
Moderna Inc. is a biotechnology company focused on developing medicines and vaccines based on messenger RNA (mRNA) technology. Its commercial portfolio includes respiratory and infectious disease vaccines, while its broader pipeline spans oncology, rare diseases, autoimmune conditions, and other therapeutic areas.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
